Dr. Naginder Sharma, MD
What this data tells you about Dr. Sharma
Dr. Naginder Sharma is a cardiovascular disease in Burleson, TX, with 19 years in practice. Based on federal Medicare data, Dr. Sharma performed 3,098 Medicare services across 2,161 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sharma received a total of $1,384 from 23 pharmaceutical and/or device companies across 68 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sharma is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity | 703 | $63 | $164 |
| Regadenoson injection (Lexiscan) for heart stress test | 396 | $44 | $175 |
| Initial hospital admission, high complexity | 284 | $138 | $459 |
| Echocardiogram, transthoracic | 273 | $153 | $569 |
| Office visit, established patient (20-29 min) | 136 | $64 | $164 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 129 | $50 | $173 |
| Office visit, established patient (30-39 min) | 122 | $97 | $243 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 119 | $60 | $225 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 119 | $67 | $400 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 118 | $343 | $1,102 |
| Electrocardiogram (EKG), 12-lead | 83 | $10 | $38 |
| Ultrasonic guidance for blood vessel access | 71 | $11 | $36 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 67 | $10 | $36 |
| Ultrasound of both sides of head and neck blood flow | 63 | $151 | $459 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 42 | $674 | $1,529 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 40 | $20 | $59 |
| Ultrasound of leg arteries or artery grafts | 35 | $192 | $592 |
| Programming of dual lead pacemaker system | 33 | $27 | $133 |
| Hospital follow-up visit, high complexity | 33 | $95 | $236 |
| Ultrasound study of arm and leg arteries | 30 | $52 | $203 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 27 | $15 | $32 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 26 | $54 | $208 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 22 | $202 | $800 |
| New patient office visit (45-59 min) | 20 | $113 | $371 |
| Review by radiologist of abdominal aorta image | 18 | $53 | $140 |
| Review by radiologist of both arms or legs arteries image | 18 | $72 | $154 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial second order branch | 17 | $159 | $812 |
| Ultrasound of heart with probe in esophagus, with report | 14 | $85 | $634 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $2 | $52 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $14 | $112 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $277 | $972 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sharma is a cardiac imaging specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sharma experienced with hospital follow-up visit, moderate complexity?
Does Dr. Sharma receive payments from pharmaceutical companies?
How do Dr. Sharma's costs compare to other cardiovascular diseases in Burleson?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology